A decade-long battle with acne is one of the biggest reasons I became a beauty journalist. With over 50 million Americans dealing with this skin condition annually, it's a struggle that's near and ...

If you've experienced acne, you're probably familiar with the host of oral medications and topical products that promise to treat breakouts. There are the more common prescription-grade options — like ...

The first-in-class topical acne treatment targets the androgen receptor. The Food and Drug Administration (FDA) has approved Winlevi® (clascoterone cream 1%; Cassiopea) for the topical treatment of ...

While Cassiopea’s Winlevi (clascoterone) is likely to be FDA approved in moderate-to-severe acne, it is at risk of diminishing clinician/patient interest following initially optimistic early uptake, ...

This new medicine is the first of its kind: a topical anti-androgen cream, which means it “blocks the effects of male sex hormones (androgens),” says New York-based dermatologist Evan Rieder, M.D. “We ...

I've had acne-prone skin since I hit puberty. While it started as small, textured bumps, over the years the condition progressed to a combination of black and whiteheads that were always relatively ...

The approval of Winlevi was based on data from 2 double-blind, vehicle-controlled phase 3 trials in 1440 patients with facial acne vulgaris. Winlevi ® (clascoterone cream 1%) is now available for the ...

The Milan, Italy-based pharmaceutical company Cassiopea S.p.A. has created a new therapeutic topical drug class to treat acne. But that’s just the beginning of its story. With its US subsidiary ...

It’s been decades since a novel acne treatment hit the scene, but that’s set to change with Cassiopea’s approval for Winlevi. The FDA on Thursday approved the new prescription acne medication, set for ...

Please provide your email address to receive an email when new articles are posted on . New data showed Winlevi reduced oil production, remained stable when used in conjunction with other topical acne ...